Morphogen-IX
Latest round
- Series B
Last raised
- Dec 2018
Total raised
- $26M
Investors
- 4
About Morphogen-IX
Established in 2015 and based in Cambridge, UK, Morphogen-IX Ltd is a biotech company that develops a drug treatment for pulmonary arterial hypertension.
Who invested in Morphogen-IX
4 investors across 2 rounds
See all investors in Morphogen-IX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Morphogen-IX
Who invested in Morphogen-IX?
Morphogen-IX has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Morphogen-IX raised?
Morphogen-IX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Morphogen-IX last raise money?
Morphogen-IX's most recent round on record is a Series B, in Dec 2018.
What does Morphogen-IX do?
Established in 2015 and based in Cambridge, UK, Morphogen-IX Ltd is a biotech company that develops a drug treatment for pulmonary arterial hypertension.
Where is Morphogen-IX headquartered?
Morphogen-IX is headquartered in Cambridge, UK.
Which VCs invest in companies like Morphogen-IX?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Morphogen-IX's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Morphogen-IX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.